Join the ISN and Guests Live on March 10 for the Latest #NephTrials Discussion on the RENAL LIFECYCLE Trial Outcomes on Dapagliflozin and CKD
The next #NephTrials will be held on March 10, 2023, at 3 p.m. CET!
Join Ron Gansevoort, primary investigator of the RENAL LIFECYCLE trial, in conversation with Michael Walsh, Roberto Pecoits-Filho, Joel Topf, Manasi Bapat, and Swapnil Hiremath. The panel will examine the composite and secondary outcomes of a randomized control trial investigating the effects of dapagliflozin on people with severe chronic kidney disease.
The #NephTrials initiative is an exciting series of conversations combining expertise from the ISN-ACT Global Trials Focus, the ISN-ACT Toolkit, and the #NephJC community.
To access the discussion:
- Follow @NephJC and @ISNkidneycare
- Type “NephTrials” in Twitter’s search bar
- Go to “latest”
- Follow the conversation #NephTrials #NephJC
